Anlotinib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
First Affiliated Hospital of Wenzhou Medical University
Overview
Anlotinib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Anlotinib clinical trials
Explore related
Medical disclaimer. This page summarizes research about Anlotinib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.